Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Pneumococcal 15-Valent Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The PCV15 vaccine (pneumococcal 15-valent vaccine) has been developed by Tergene Biotech and manufactured atAurobindo Pharma with capabilities in vaccines development and manufacturing.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
December 27, 2022
Lead Product(s) : Pneumococcal 15-Valent Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable